metsera glp-1 Reports Highly Competitive Results from Ongoing Trial of Novel, Potential Once-Monthly Injectable Receptor Agonist MET-097 Pfizer Acquires Metsera for $4.9
Pay in 4 interest-free payments of $6.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14

























